Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/2012
06/19/2012US8202845 Means and methods for the specific modulation of target genes in the CNS and the eye and methods for their identification
06/19/2012US8202724 Methods of controlling proliferation and differentiation of stem and progenitor cells
06/19/2012US8202688 Synergistic mixtures; hepatitis virus
06/19/2012US8202517 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/19/2012CA2406169C Polyamide nucleic acid derivatives, and agents and processes for preparing them
06/19/2012CA2398432C Modulation of oligonucleotide cpg-mediated immune stimulation by positional modification of nucleosides
06/19/2012CA2319872C Pharmaceutical composition for the treatment of hepatocellular carcinoma
06/19/2012CA2311166C Nucleic acids involved in the responder phenotype and applications thereof
06/14/2012WO2012079046A2 Compositions and methods for inhibiting expression of klf-1 and bcl11a genes
06/14/2012WO2012079043A2 Targeting kidney mesangium with nanoparticles of defined diameter
06/14/2012WO2012078967A2 Compositions and methods for increasing erythropoietin (epo) production
06/14/2012WO2012078637A2 Composition and method for oligonucleotide delivery
06/14/2012WO2012078586A2 Pharmaceutical composition comprising nanog shrna, and method of usnig nanog shrna to treat cancer
06/14/2012WO2012078558A2 microRNAs AS NEW THERAPEUTIC TARGETS FOR THE PREVENTION AND/OR TREATMENT OF RETINOPATHY
06/14/2012WO2012076694A1 Cancer gene therapy using nucleic acids encoding us28 and g-protein
06/14/2012WO2012076452A1 Release of endogenous il7 by the infusion of genetically modified cells for immune reconstitution
06/14/2012WO2012075602A1 Ultrasonic microbubble target-locating controlled releasing drug/gene device and target transfer method
06/14/2012WO2012053741A3 Nucleic acid molecules inducing rna interference, and uses thereof
06/14/2012WO2012047679A3 Consensus antigen constructs and vaccines made there form, and methods of using same to treat malaria
06/14/2012WO2012019188A3 Methods and compositions for the inhibition of fructokinase
06/14/2012WO2012012695A3 A method for the treatment of obesity
06/14/2012WO2012012676A3 Use of mir-29 for cell protection
06/14/2012WO2011008939A3 Porous-wall hollow glass microspheres as carriers for biomolecules
06/14/2012US20120149893 Modulation of eif4e-bp2
06/14/2012US20120149890 Polynucleotides Encoding Thymidine Kinase Mutants
06/14/2012US20120149762 Gene and Protein Relating to Hepatocellular Carcinoma and Methods of Use Thereof
06/14/2012US20120149755 Antisense oligonucleotide modulation of raf gene expression
06/14/2012US20120149109 Modulation of transthyretin expression
06/14/2012US20120149102 Agonist and antagonist peptides of carcinoembryonic antigen (cea)
06/14/2012US20120149069 Methods and compositions for seamless cloning of nucleic acid molecules
06/14/2012US20120149044 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
06/14/2012US20120148627 Compositions and Methods for Treatment of Neoplastic Disease
06/14/2012US20120148565 Increasing lifespan by modulation of wwp-1 and ubc-18
06/14/2012US20120148555 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
06/14/2012US20120148545 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
06/14/2012US20120148498 Compositions and Methods for the Systemic Treatment of Arthritis
06/13/2012EP2463371A2 Sirna conjugate and preparation method thereof
06/13/2012EP2462952A1 Cancer gene therapy using nucleic acids encoding US28
06/13/2012EP2462230A2 Methods and compositions for targeted gene modification
06/13/2012EP2461833A1 Vaccine composition comprising 5'-cap modified rna
06/13/2012EP2461819A2 Methods and compositions for treating trinucleotide repeat disorders
06/13/2012EP1828390B1 Chimeric vectors
06/13/2012EP1720571B1 Method of treating hemolytic disease
06/13/2012EP1459070B1 Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers
06/13/2012EP1449542B1 Hgf as genetic remedy for parkinson's disease
06/13/2012EP1447095B1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant
06/13/2012EP1442057B1 Use of a half-transporter protein of the abcg-family for selecting cells and in gene therapy
06/13/2012EP1414471B1 Therapeutic agents comprising pro-apoptotic proteins
06/13/2012EP1355666B1 Use of repulsive guidance molecule (RGM) and its modulators
06/13/2012EP1235594B1 Inhibition of secretion from non-neuronal cells
06/13/2012CN102498213A Widespread gene delivery to the retina using systemic administration of AAV vectors
06/13/2012CN102498211A Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof
06/13/2012CN102497887A Composition for delivery of genetic material
06/13/2012CN102492723A Preparation method of recombinant adenovirus and application thereof
06/13/2012CN102492095A Construction of bio-reducible efficient cation gene vectors taking polysaccharides as frameworks with ATRP (Atom Transfer Radical Polymerization) method
06/13/2012CN102488903A Application of miR-224 to preparation of medicament for treating non-small cell lung cancer
06/13/2012CN102488902A Albumin-modified PAMAM self-assembly transgenic composition, preparation method and application thereof
06/13/2012CN102488895A Porcine circovirus, porcine parvovirus and porcine reproductive and respiratory syndrome virus triple virus-like particle vaccine and its preparation method
06/13/2012CN101648011B Tumor targeting recombinant DNA vaccine, preparation method thereof and application thereof
06/13/2012CN101307085B SiRNA and recombination lentivirus from preventing hepcidin from regulating protein and uses thereof
06/12/2012US8198430 Immunogenic sequences
06/12/2012US8198428 Identification of novel genes coding for small temporal RNAS
06/12/2012US8198421 Modified factor VIII and factor IX genes and vectors for gene therapy
06/12/2012US8198294 Treatment of dyskinesia
06/12/2012US8198265 Regulation of T cell-mediated immunity by tryptophan
06/12/2012US8198258 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
06/12/2012US8198257 CYP46A1 gene for the treatment of alzheimer's disease
06/12/2012US8198254 Annexin A9 (ANXA9) biomarker and therapeutic target in epithelial cancer
06/12/2012US8198251 Combination motif immune stimulatory oligonucleotides with improved activity
06/12/2012US8198235 Use of GILZ protein expressed in dendritic cells to modulate an antigen-specific immune response
06/12/2012US8197825 Recombinant MVA virus and the use thereof
06/12/2012US8197820 HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/12/2012US8197806 Stimulation of cartilage formation using reduced pressure treatment
06/12/2012CA2404325C Immunotherapeutic methods and compositions
06/12/2012CA2363269C Dna vaccination for treatment of autoimmune disease
06/12/2012CA2262756C A tumor necrosis factor related ligand
06/12/2012CA2249746C Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis
06/12/2012CA2214830C Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
06/12/2012CA2180473C Cloning and characterization of h.pylori flba gene. production of aflagellate strains
06/07/2012WO2012075490A2 Anti-podoplanin antibodies and methods of use
06/07/2012WO2012075462A2 Methods and compositions for treatment of muscular dystrophy
06/07/2012WO2012075379A2 Liquid viral formulations
06/07/2012WO2012075376A2 Lyophilized viral formulations
06/07/2012WO2012075184A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof
06/07/2012WO2012075136A2 Targeting of cyp1b1 in the treatment of head and neck cancer and lung cancer
06/07/2012WO2012075114A2 Nucleic acid-polymer conjugates and uses thereof
06/07/2012WO2012075040A2 mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
06/07/2012WO2012075027A1 Embedded chimeric peptide nucleic acids for generation of induced pluripotent stem cells
06/07/2012WO2012074277A2 Novel hybrid promoter and recombinant vector comprising the same
06/07/2012WO2012074038A1 Modified single-strand polynucleotide
06/07/2012WO2012073253A1 Therapeutic uses of mirnas/compounds that activate tumor suppressor genes/mirnas
06/07/2012WO2012072840A1 Use of rgs-14 protein for the prevention and/or treatment of a cognitive disorder and/or a memory disorder
06/07/2012WO2012041867A3 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
06/07/2012WO2012027462A3 Compositions and methods for treating neoplasia
06/07/2012US20120142760 Compositions and methods for regulated protein expression in gut
06/07/2012US20120142756 mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
06/07/2012US20120142611 Repeat protein from collection of repeat proteins comprising repeat modules
06/07/2012US20120142609 Non human animal models for increased retinal vascular permeability
06/07/2012US20120142099 Novel bak binding protein, dna encoding the protein, and methods of use thereof
06/07/2012US20120142071 Thymidine Kinase Mutants
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 870